A prospective study to validate the efficacy on the induction, consolidation, and maintenance therapy for the elderly multiple myeloma patients
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 10 Oct 2018 Planned End Date changed from 30 Sep 2020 to 30 Mar 2016.
- 10 Oct 2018 Status changed from recruiting to discontinued.
- 02 Jul 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.